Robert C. Salisbury, Director at ENZON PHARMACEUTICALS INC (ENZN), bought 10,000 shares at $3.24 ($32K) on 2008-11-13, disclosed to the SEC on 2008-11-14.
Open-market purchase of $32k ENZN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.19 | 2,873 | $9K | 28.5% |
| 2 | $3.20 | 600 | $2K | 6.0% |
| 3 | $3.21 | 1,897 | $6K | 18.9% |
| 4 | $3.23 | 500 | $2K | 5.0% |
| 5 | $3.24 | 100 | $324 | 1.0% |
| 6 | $3.25 | 4,030 |
| $13K |
| 40.7% |
| Total | $3.22 avg | 10,000 | $32K | 100% |